AzTrials
AzTrials

ACL InjuryAugmentationNCT05391672

Augmentation of Partial Anterior Cruciate Ligament Tear: Early Results

A study testing we will do ACL augmentation surgery to the patients who have partial ACL tear in people with ACL Injury and ACL Augmentation, run by Assiut University at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Clinical evaluation for the patients with partial ACL tear who had ACL augmentation Read more about this study

Who is it for?
Ages 15 to 50 years
Conditions the study is for
ACL Injury, ACL Augmentation
What is being tested?
we will do ACL augmentation surgery to the patients who have partial ACL tear
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteEgypt
Study dates
9 Jun 2022to 19 Mar 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 50 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • age from 15 to 50 years old
  • Partial ACL tear without any other ligament injury
  • with and without meniscal tear
  • with and without knee deformity
  • recent and chronic injury

Who cannot join

  • younger than 15 and older than 50 y
  • multiligament injury
  • complete ACL tear
  • failed ACL reconstruction or repair

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Michael Mikhaeil, Resident contact

01289375910

mickelmikhaa5@gmail.com

Mohamed Abd-El Radi, Lecturer contact

01225338766

mradi@aun.edu.eg

Egypt1 site, 1 recruiting
  • Assiyt University

    Asyut

    Mickel Mikhaa, resident, +201289375910, mickelmikhaa5@gmail.com

    Recruiting

Other trials in Egypt

About this study

Clinical evaluation for the patients with partial ACL tear who had ACL augmentation

Read the detailed description

we will do a clinical evaluation depending mainly on IKDC score for patients with partial ACL tear who undergoing ACL augmentation surgery inside Assiut university hospital

Being tested
we will do ACL augmentation surgery to the patients who have partial ACL tear
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • we will do ACL augmentation surgery to the patients who have partial ACL tearProcedure or surgery

    we will do ACL augmentation surgery to the patients who have ACL partial tear using hamstring graft and fixation of the graft to the femoral part by adjustable loop and tibial part with Bio or peak screws +\- staples.

Study groups in NCT05391672
Study groupRoleWhat they receive
Augmentation groupOtherWe will use hamstring graft in which fixation of graft will be by adjustable loop devices for femoral part fixation \& Bioscrews +/- staples for tibial part fixation
Receives: Procedure: we will do ACL augmentation surgery to the patients who have partial ACL tear

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The main outcome is difference in IKDC scores between the patients

    we will evaluate the clinical outcome post operative mainly according to the difference in IKDC score between the patients

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 May 2022
  2. Study start9 Jun 2022
  3. Primary completion19 Mar 2026 (estimated)
  4. Study completion19 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
prospective case series study
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05391672
Sponsor's protocol ID
17101888
Acronym
Augmentation
Status last verified
Dec 2025
First submitted
21 May 2022
Last updated
22 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Gobbi A, Whyte GP. Long-term Outcomes of Primary Repair of the Anterior Cruciate Ligament Combined With Biologic Healing Augmentation to Treat Incomplete Tears. Am J Sports Med. 2018 Dec;46(14):3368-3377. doi: 10.1177/0363546518805740. Epub 2018 Nov 6.

    PubMed 30398894
  • Dallo I, Chahla J, Mitchell JJ, Pascual-Garrido C, Feagin JA, LaPrade RF. Biologic Approaches for the Treatment of Partial Tears of the Anterior Cruciate Ligament: A Current Concepts Review. Orthop J Sports Med. 2017 Jan 25;5(1):2325967116681724. doi: 10.1177/2325967116681724. eCollection 2017 Jan.

    PubMed 28210653
  • Sabat D, Kumar V. Partial tears of anterior cruciate ligament: Results of single bundle augmentation. Indian J Orthop. 2015 Mar-Apr;49(2):129-35. doi: 10.4103/0019-5413.152394.

    PubMed 26015599
  • Sharp JW, Kani KK, Gee A, Mulcahy H, Chew FS, Porrino J. Anterior cruciate ligament fixation devices: Expected imaging appearance and common complications. Eur J Radiol. 2018 Feb;99:17-27. doi: 10.1016/j.ejrad.2017.12.006. Epub 2017 Dec 9.

    PubMed 29362147

Questions about this trial

What is this clinical trial studying?

A study testing we will do ACL augmentation surgery to the patients who have partial ACL tear in people with ACL Injury and ACL Augmentation, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Michael Mikhaeil, Resident (01289375910, mickelmikhaa5@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The main outcome is difference in IKDC scores between the patients (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05391672, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in